Certificate Programs Can Help Scientists Transition to Alternative Careers

By now, I think that most BioJobBlog readers understand that the job market for life scientists is lousy and that it isn’t likely to improve anytime soon. I know that many of you have spent close to 10 years training for a shot at an R&D job but the reality is that everybody needs to work to put food on the table—whether or not you find a job in your chosen profession. To that end, now may be a good time for those of you who are finding it difficult to land a job to consider one more year of training to get a certificate in a field that keeps you in science but not in R&D.

I came across interesting post today at the Resume Bear blog that discussed 10 certificate programs that can help people transition to new careers to find jobs. Interestingly, four of the programs are good fits for life scientists who are willing modify their careers to be gainfully employed. They are:

Clinical Trials Design and Management

“Pharmaceutical drug and medical device development is one of the premier industries of the 21st century, and the success of this vital industry depends upon the complex process of studying new products to verify their effectiveness and safety.”

Regulatory Affairs

Professionals are needed to guide drug development and medical device companies through FDA imposed regulation issues pertinent to the pharmaceutical and biological industry.”

Project Management

“As project cycles get shorter – and budgets get leaner – project managers are vital to the success of organizations today.”

Copyediting

“Bridging the gap between writers and publishers – especially technical and nonfiction copyediting – is one of today’s most marketable skills for both full-time and freelance work.”

Another one that was not on the list biotechnology certificate programs in which students learn about product development, regulatory affairs and best business practices in the life sciences industry.

Not surprisingly, many certificate programs are offered at local community colleges and frequently online. For regulatory affairs training you might try the Drug Information Association and Regulatory Affairs Professionals Society. The Project Management Institute offers training in project management and the Editorial Freelancers Association offers its members courses in copyediting. Mercer County College in West Windsor NJ in association with a local clinical research organization developed a “hands-on” certificate program in clinical trials design and management

In my opinion, certificate programs are worth checking out. They are designed for working professionals (courses are typically given in the evenings and weekends); usually only take 12 months to complete (what is one more year in the scheme of things) and improves the likelihood of finding a job because you now have a marketable skill set! It certainly beats collecting unemployment or sleeping in your old bed at your parent’s home—or not?

Hat tip to Resume Bear

Until next time...

 SocialTwist Tell-a-Friend

Invitrogen to Acquire Applied Biosystems

The consolidation trend in the US life sciences industry continues. Carlsbad, CA-based Invitrogen, a provider of cells, molecular and biochemical probes and reagents used in life sciences research,announced on Thursday that it will acquire (merge) with automated DNA sequencer manufacturer Applied Biosystems (ABS).  Invitrogen will pay $6.7 billion in cash and stock to buy ABS which is an independent unit of Applera Corporation.

As most of you know, ABS supplied hundreds of automated DNA sequencing machines ($300,000 per machine) that were used to sequence the human genome. The advent of automated DNA sequencers in the mid to late 1990s helped (along with Craig Venter) to speed up efforts to complete the Human Genome project which officially began in 1990. The first draft of the human genome was published in 2001. Unfortunately for ABS, it was unable to refocus and adjust to changing business conditions after the government-sponsored human genome project ended in the early 2000s.  Attempts to reinvent the company included moving into commercial businesses like selling equipment to test food for pathogens or DNA from crime scenes.

The deal, if approved by regulators, would create a giant supplier of machines and materials used by academic and pharmaceutical industry research laboratories, with about $3.5 billion in annual sales. Although the deal makes sense from a business perspective, it is likely that there will be a “reallocation of corporate resources” once the merger is approved by European and US regulators.

Until next time….

Good Luck and Good Job Hunting (try Carlsbad, it is a great place)!!!!!!!!